Clinical research

Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus

EuroIntervention 2014;10:74-82 published online ahead of print December 2013. DOI: 10.4244/EIJV10I1A13

Si-Hyuck Kang
Si-Hyuck Kang1, MD; Keun Ho Park, MD2; Hyo-Suk Ahn1, MD; Kyung Woo Park1, MD; Young Joon Hong2, MD; Bon-Kwon Koo1, MD; Myung Ho Jeong2, MD; Hyo-Soo Kim*1, MD
1. Cardiovascular Centre, Seoul National University Hospital, Seoul, South Korea; 2. Heart Research Centre of Chonnam National University Hospital, Gwangju, South Korea

Aims: Patients with diabetes mellitus have a higher risk of adverse events after percutaneous coronary intervention (PCI). This study aimed to elucidate the relative efficacy of everolimu

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

diabetes mellitusdrug-eluting stentspercutaneous coronary intervention
Read next article
Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes

Latest news

NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022
NEW
EuroIntervention's new Impact Factor!
June 28, 2022